March 30, 2017
Crescita Therapeutics (TSX:CTX) released their fourth quarter and 2016 financial results.
March 27, 2017
GeoVax Labs has successfully concluded a clinical trial for its vaccine candidate GEO-ZM02 seeking protection for the Zika virus.
March 24, 2017
Neovasc (TSX:NVCN) announced their financial results for 2016 and their fourth quarter.
March 16, 2017
Knight Therapeutics (TSX:GUD) announced their financial results for 2016 and its fourth quarter.
December 8, 2016
Pharmaceutical companies have developed numerous strategies to counter the patent cliff. One such tactic? Capitalizing on the personalized medicine market....